Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option
The loss of muscle among older individuals can lead to an increased risk of falls and fractures
Only the lyophilized powder should ever be frozen
Standardized protocols across hundreds of clinics help ensure consistency at scale
D.SchuppP.LaucknerJ.VakhrushevaO.SladeK
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 20.15
US$ 22.40
:format(webp))
US$ 26.19
